• Home
  • About us
  • Partners
  • News
  • NEWS
  • Contact us
www.amlvaccin.eu
  • Home
  • About us
  • Partners
  • News
  • NEWS
  • Contact us

Geen categorie

  • Home
  • /Category ' Geen categorie '

AML-VACCiN promoted by the European Commission

On February 28 2020 Jean-Eric Paquet (Director-General of the Research and Innovation department) wrote the following on Twitter: ”Rare diseases are a priority area of research funding for the EU. This is why we will continue to ...

Continue reading

  • 03 Mar
  • amlvaccin
  • Geen categorie
  •  Like

Third AML-VACCiN Consortium Meeting

On 13 June 2019 the Third AML-VACCiN Consortium Meeting was held in Amsterdam, The Netherlands. During this meeting progress on the overall objectives, financial status and encountered hurdles were discussed. Good progress was reported ...

Continue reading

  • 14 Jun
  • amlvaccin
  • Geen categorie
  •  Like
  • Categories

    • Article
    • Geen categorie
    • News
  • Recent Posts

    • AML-VACCiN promoted by the European Commission
    • Want to read more about the role of relapse vaccines in AML? Please read the article on this topic published in the November-December 2019 edition of MedNous
    • Third AML-VACCiN Consortium Meeting
    • Presentations of the preclinical results at the annual CCBIO Symposium
    • Presentation of the preclinical data at the annual CIMT meeting
  • PROJECT INFO

    This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667713. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.